Saturday 17 October 2026 Export SRPT’s income statement to Excel — free account

Sarepta Therapeutics, Inc.

Sarepta Therapeutics, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.2 billion, up 15.6% from fiscal 2024. In the quarter to June 2026, revenue fell 34.3%, EPS fell 102.5%, free cash flow fell 14.5% and total debt fell 25.6%, each against the same quarter a year earlier. Revenue growth for ten consecutive years.

17.06 0.73 −4.10%

Follow SRPT

Alert me

Market cap: $1.9B
P/E: 0.0×
Fwd P/E: 4.4×
Dividend yield: —
F-score: 3/9
Altman Z: −0.97
Beneish M: −3.41
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
P/E ratio Full definition →	0.00	35.27	0.00	0.00	+8 more quarters Free account
P/S ratio Full definition →	0.96	1.05	0.98	0.80
P/FCF ratio Full definition →	25.27	21.11	0.00	0.00
P/Operating CF Full definition →	9.61	(11.27)	16.42	(132.44)
P/B ratio Full definition →	1.24	1.52	1.89	1.46
Price to Tangible BV Full definition →	1.25	1.53	1.91	1.48
EV/Sales Full definition →	1.04	1.17	0.97	0.91
EV/EBITDA Full definition →	0.00	9,628.22	0.00	0.00
EV/Operating CF Full definition →	18.43	14.61	(10.39)	(9.02)
EV/FCF Full definition →	27.28	23.66	(6.77)	(5.68)
Quick Ratio Full definition →	2.32	2.10	1.22	1.35
Current Ratio Full definition →	4.42	4.63	2.32	2.95
Net Debt/EBITDA Full definition →	2.59	0.50	0.27	(2.14)
Debt/Assets Full definition →	26.58%	26.37%	24.75%	29.63%
Debt/Equity Full definition →	0.55	0.56	0.73	0.78
Asset Turnover Full definition →	0.57	0.66	0.60	0.68
Operating CF/Net income Full definition →	(40.30)	(0.61)	(0.46)	0.08
Capex/Depreciation Full definition →	(0.06)	(0.31)	(0.77)	(1.66)
Research and Development Expense of Revenue Full definition →	22.74%	21.07%	73.45%	54.81%
Selling, General and Administrative Expense of Revenue Full definition →	26.82%	14.91%	28.97%	23.01%
Intangible Assets out of Total Assets Full definition →	0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →	6.10%	4.02%	6.78%	3.74%
Graham Net Nets Full definition →	0.30	0.28	0.15	0.28
Graham Number Full definition →	0.00	14.11	0.00	0.00
Earnings Yield Full definition →	(8.03%)	2.84%	(33.15%)	(14.22%)
Free Cash Flow Yield Full definition →	3.96%	4.74%	(14.64%)	(20.13%)
Revenue per Share Full definition →	3.81	6.96	4.42	3.98
Operating CF per Share Full definition →	1.87	(1.93)	1.31	(0.15)
Capex per Share Full definition →	(0.01)	(0.03)	(0.04)	(0.29)
Free Cash Flow per Share Full definition →	1.86	(1.96)	1.27	(0.43)
Cash per Share Full definition →	7.48	6.22	9.39	8.49
Shareholders Equity per Share Full definition →	14.49	14.34	11.39	13.17
Interest Debt per Share Full definition →	0.00	0.00	0.00	0.00
Book value per Share Full definition →	14.49	14.34	11.39	13.17
Free Cash Flow Full definition →	196.52	(205.76)	127.48	(43.26)
Working Capital Full definition →	1,720.92	1,810.71	1,442.65	1,800.88
Capital Expenditures Full definition →	(0.55)	(3.08)	(3.73)	(28.67)
Net Current Asset Value Full definition →	563.11	636.04	328.86	548.99
EV/EBIT Full definition →	0.00	0.00	0.00	0.00
Capex to Sales Full definition →	0.00	0.00	0.01	0.07
Price to Operating Income Full definition →	0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →	452.06	527.09	500.11	415.13
Average Payables Full definition →	93.84	113.24	247.64	106.39
Average Inventory Full definition →	949.15	971.27	832.35	821.55
Average Assets Full definition →	3,434.16	3,322.16	3,656.44	3,546.69
Average Common Equity Full definition →	1,442.59	1,323.91	1,334.18	1,270.60

Fold the line items

Columns are period end dates

Stockrow Weekly